President Biden Nominates Chiquita Brooks-LaSure to CMS Administrator
Brooks-LaSure has more than two decades of experience in health policy and played a crucial part in the passage of the Affordable Care Act.
Tag Archives: ACA
Was Device Tax Responsible for 29k Job Loss?
The U.S. Department of Commerce reported a 7.2% decline in jobs in the medical device industry.
Trump’s Impact, Pricing, R&D Funding and Cybersecurity Among Top Trends of New Year
It’s too early to tell how the new administration will affect the device industry, but user fees, the ACA and the FDA regulatory process are top of mind.
Report: President-Elect Trump’s Healthcare Approach Uncertain, Top 10 2017 Issues
‘Value’ is the common thread in PwC’s annual report on top health industry trends.
MedTech and the 2016 Election: Who Wins?
The candidates have said little about what they will do for the medical device industry.
Device Tax on Hold for Two Years
The Senate vote is good news for industry, which has fought against the tax for years.
When Can I Appeal My Health Insurance Carrier’s Decision?
That depends on where you sit.
“Tax Effect Not Minimal and is Responsible for 18,500 Job Losses”
The medical device tax has a “profound negative effect” on the nation’s jobs and innovation, AdvaMed President and CEO Stephen Ubl and Medical Imaging & Technology Alliance Executive Director Gail Rodriguez explain in an editorial.
The medical device tax has a “profound negative effect” on the nation’s jobs and innovation, AdvaMed President and CEO Stephen Ubl and Medical Imaging & Technology Alliance Executive Director Gail Rodriguez explain in an editorial.
How is Industry Dealing with Tax – Survey Results Tell Story
The U.S. Medical Device Excise Tax continues to draw scorn from industry advocates as a jobs killer. However, new data from a survey tells a different story about how executives are compensating for costs of the tax, and that story varies considerably by size of company.
The U.S. Medical Device Excise Tax continues to draw scorn from industry advocates as a jobs killer. However, new data from a survey tells a different story about how executives are compensating for costs of the tax, and that story varies considerably by size of company.
The Appeals Process
Presenting clinical evidence to payers is the most efficient method of gaining coverage. But when this strategy is unsuccessful or hits a wall, a ground-up approach is required, relying on consistent and steady support from local physician champions that demonstrates broad acceptance of a technology.
Presenting clinical evidence to payers is the most efficient method of gaining coverage. But when this strategy is unsuccessful or hits a wall, a ground-up approach is required, relying on consistent and steady support from local physician champions that demonstrates broad acceptance of a technology.
